Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Neoplasms 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Pain 1Leukemia, Myeloid, Acute 1Gastrointestinal Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Anxiety Disorders 1

Interventions

Specimen Handling 4Gemcitabine 4fludarabine 3aldesleukin 3Radiosurgery 3Oxaliplatin 3Fluorouracil 3Endoscopic Mucosal Resection 3Cyclophosphamide 3Cetuximab 3Bevacizumab 3130-nm albumin-bound paclitaxel 3Tomography, X-Ray Computed 2Surveys and Questionnaires 2Sunitinib 2Pemetrexed 2IDRX-42 2Folfox protocol 2Endoscopy, Digestive System 2Biopsy 2trastuzumab deruxtecan 1tislelizumab 1sodium thiosulfate 1sodium propionate 1semaglutide 1s-formylglutathione hydrolase 1repotrectinib 1regorafenib 1plecanatide 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Massage × 90 days × Clear all
NCT02221700 2026-03-09

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

M.D. Anderson Cancer Center

Phase NA Active not recruiting
90 enrolled
BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡